Sunday, May 30, 2021

People Want an Alzheimer’s Drug. Aducanumab Isn’t the One.

An F.D.A. sign-off for aducanumab would make finding a good treatment harder.

from NYT > Top Stories https://ift.tt/34psXgz
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Günther Uecker, Who Punctuated His Art With Nails, Dies at 95

A member of the German collective Zero Group, he hammered thousands of nails — into columns, chairs, canvases — expressing the power of repe...